webinar register page

Panelists: Dr. Josh Woolley, Amir, Dr. Erin Michalak
#TalkBD LIVE: Psychedelics & Bipolar Disorder
Our next #TalkBD livestream and Q&A focuses on a growing area of research: bipolar disorder and psychedelics. Please register to receive the link and reminders to join the event!

Panelists: Dr. Josh Woolley, Amir, Dr. Erin Michalak

For more info on this livestream, or to submit a question for our panelists, visit: https://crestbd.ca/TalkBD-18

Nov 22, 2021 12:00 PM in Pacific Time (US and Canada)

* Required information


Dr. Josh Woolley
Director @UCSF BAND Lab
Dr. Josh Woolley is currently the principal investigator and director of UCSF’s Bonding and Attunement in Neuropsychiatric Disorders (BAND) Laboratory. The lab’s mission is to understand mechanisms of social connection among individuals with mental illness and to test new treatments. The BAND Lab studies psychedelics as novel therapeutics for multiple conditions, including bipolar disorder. He’s also the director of the translational psychedelic research program at UCSF.
Dr. Erin Michalak
Professor @CREST.BD
Erin is the Founder and Network Lead of CREST.BD, and Professor at UBC Psychiatry. Her research in mental health, patient-oriented research and quality of life in bipolar disorder is globally recognized. Erin spearheaded the development of the first BD-specific quality of life scale, the QoL.BD. The QoL.BD has seen rapid uptake internationally and is now the gold-standard for BD quality of life assessments. Under Erin, CREST.BD also launched an online version of the QoL.BD, and the Bipolar Wellness Centre, a web portal of scientifically validated wellness strategies for BD. In 2018, she was awarded the CIHR Gold Leaf Prize for Transformation in Patient Engagement.
Peer Researcher @CREST.BD
Amir is a recent graduate of UBC in a bachelors of science in cognitive systems where he focused on cognition and the brain. He is a peer researcher at CREST.BD and is starting his role as a peer mental health support worker at Foundry. As an individual with lived experience, he has been a researcher on UBC and UCSF's joint project on investigating the use of Psilocybin in individuals with bipolar disorder.